Home›Stock Screener›KMS Medisurgi

KMS Medisurgi Share Price Today | Stock Price & KMS Medisurgi Share Screener

KMSMEDI Healthcare Equipment & Supplies

Track the current KMS Medisurgi share price and stock price live with TickJournal's free stock screener. Track KMS Medisurgi marketcap in USD to gauge the company's total market size. Use the KMS Medisurgi stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today KMS Medisurgi opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

KMS Medisurgi Market Cap ₹46.00 Cr.
KMSMEDI P/E Ratio (TTM) -
KMS Medisurgi P/B Ratio 5.53
EPS (TTM) ₹0.74
Dividend Yield 0.04%
Debt to Equity 0.10
KMSMEDI 52 Week High -
KMS Medisurgi 52 Week Low -
Operating Margin -
Profit Margin -
KMSMEDI Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹11.00
Total Equity ₹8.00

KMS Medisurgi Share Price Chart

Track the current stock price of KMS Medisurgi with an interactive chart. Analyse KMSMEDI share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete KMS Medisurgi stock quote in one place.

KMS Medisurgi Company Profile - Fundamental Screener

Screen KMS Medisurgi company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KMSMEDI shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Equipment & Supplies industry, and it trades under ISIN INE870V01014.

Company Details

Classification

Sector Healthcare
Industry Healthcare Equipment & Supplies
Sub-Sector Healthcare Equipment & Supplies
Segment E

Identifiers and Leadership

ISIN INE870V01014

KMS Medisurgi Balance Sheet Screener

Screen KMSMEDI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹11, up from ₹10 in 2025.

Latest statistics put total assets at ₹11 and shareholder funds at ₹8, with a leverage ratio of 0.10.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 11 10 11 10 10 9 9 11 10 9
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 3 2 2 2 2 2 2 2 2 3

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 1 1 1 1 1 1 1 1 1 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 8 8 8 7 7 7 6 6 6 4
Share Capital 3 3 3 3 3 3 3 3 3 2
Reserves & Surplus 5 5 4 4 3 3 3 3 3 1

KMS Medisurgi Income Statement Screener - Profit & Revenue Analysis

Screen KMS Medisurgi income statement and profit fundamentals. Analyze KMSMEDI quarterly results. KMS Medisurgi reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹12 and net profit of ₹0.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 0 12 14 14 11 10 8 10 10 8 8 9 9
Expenses 0 11 13 13 10 10 7 10 10 7 7 8 8

Operating Costs and Margins

EBITDA 0 1 1 1 1 1 1 1 1 1 1 1 1
Operating Profit % 0.00% 7.00% 7.00% 6.00% 9.00% 5.00% 7.00% 6.00% 3.00% 6.00% 12.00% 10.00% 8.00%
Depreciation 0 1 0 0 0 0 0 0 0 1 1 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 0 1 1 1 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 0 1 1 0 0 0 0 0 0 0 0
EPS 0.00 0.74 1.33 1.38 1.74 0.65 0.37 0.34 0.37 0.00 0.89 1.14 0.63

KMS Medisurgi Cash Flow Screener - Liquidity Fundamentals

Screen KMSMEDI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹2, and net cash flow was an inflow of ₹1.

Over the same period, investing activities used ₹1 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 2 1 1 1 0 1 -1 1 -2 1
Investing Activities -1 -1 -1 -1 0 0 0 0 0 -1

Financing and Net Cash

Financing Activities 0 0 -1 0 0 0 0 -1 2 2
Net Cash Flow 1 0 0 0 0 0 -1 0 0 2

KMS Medisurgi Shareholding Pattern Screener

See KMS Medisurgi shareholding pattern with promoter, FII, and DII holdings. Check KMS Medisurgi promoter holding and ownership changes for KMSMEDI on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 74.42%, foreign institutions 0.00%, domestic institutions 0.00% and the public 23.39%, spread across 64 shareholders.

The shareholder count was 64 in 2026-Mar, compared with 63 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 74.42% 74.42% 74.42% 74.42% 74.42% 74.42% 74.42% 74.42%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 23.39% 23.39% 23.39% 21.70% 23.03% 23.39% 23.39% 21.58%
Other Holding 2.18% 2.18% 2.18% 3.88% 2.55% 2.18% 2.18% 4.00%
Shareholder Count 64 63 63 59 67 64 64 59

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by KMS Medisurgi. KMS Medisurgi dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.05 per unit for 2026-March, a yield of 0.04%, compared with ₹0.05 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.05, ₹0.05 and ₹0.05 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.05 0.04%
2025-March ₹0.05 0.04%
2024-March ₹0.05 0.04%
2023-March ₹0.05 0.04%
2022-March ₹0.05 0.07%
2021-March ₹0.05 0.15%
2020-March ₹0.05 0.15%
2019-March ₹0.05 0.15%
2018-March ₹0.05 0.17%
2017-March ₹0.05 0.17%

KMS Medisurgi Stock Index Membership - Nifty & Sensex

See which indices include KMS Medisurgi stock. Check KMSMEDI index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

KMS Medisurgi is not part of any tracked indices.
Only major market indices are tracked in our system.

KMS Medisurgi Market Events Screener - Corporate Actions

Get KMS Medisurgi corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check KMS Medisurgi stock events that may affect KMSMEDI share price, along with derivatives, futures and options activity and sector gainers.

14 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.

It is followed by Annual General Meeting dated September 30, 2026 and Dividend dated September 23, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-14 2026-11-14 Quarterly Result Announcement NA 4.97%
2026-09-30 2026-09-30 Annual General Meeting NA 0.00%
2026-09-23 2026-09-23 Dividend ₹ 0.05 /share 0.00%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 0.00%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 0.00%
2025-09-30 2025-09-30 Annual General Meeting NA 0.00%
2025-09-23 2025-09-23 Dividend ₹ 0.05 /share 0.00%
2025-05-30 2025-05-30 Quarterly Result Announcement NA 0.00%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 0.00%
2024-09-30 2024-09-30 Annual General Meeting NA 0.00%
2024-09-23 2024-09-23 Dividend ₹ 0.05 /share 0.00%
2023-09-22 2023-09-23 Dividend ₹ 0.05 /share 0.00%
2022-09-22 2022-09-23 Dividend ₹ 0.05 /share 0.44%
2021-09-21 2021-09-23 Dividend ₹ 0.05 /share 0.29%

KMS Medisurgi Competitors Screener - Peer Stocks Comparison

Screen KMSMEDI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Molbio Diagnostics 17,104 120.80 1,455 41.57% 164 60.75
Poly Medicure 16,815 53.80 1,995 13.43% 321 64.63
Sahajanand Medical Technologies 5,649 79.90 1,219 17.64% 69 75.49
Tarsons Products 1,653 221.00 447 9.38% 14 47.58
Laxmi Dental 1,100 33.80 286 18.15% 26 57.90
Q-Line Biotech 1,033 18.40 347 7.89% 56 30.31
Hemant Surgical Industries 887 51.40 238 112.99% 18 63.65
Vasa Denticity 833 71.00 283 12.77% 10 65.05
Osel Devices 619 22.50 295 57.88% 29 50.35
Fabtech Technologies 617 17.00 431 28.40% 38 53.39

KMS Medisurgi Company Announcements - News & Reports Screener

Screen KMSMEDI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 19, 2026.

The next most recent announcements are dated November 19, 2026 and November 4, 2026.

Date Update Actions
2026-11-19 Submission Of Unaudited Financial Results For The Half-Year Ended September 30 2026. -
2026-11-19 Board Meeting Outcome for Submission Of Unaudited Financial Results For The Half-Year Ended September 30 2026 -
2026-11-04 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday November 14 2026 -
2026-10-21 Non-Applicability Of Report On Corporate Governance Pursuant To Regulation 27(2) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-10-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Announcement under Regulation 30 (LODR)-Cessation -
2026-10-01 Announcement under Regulation 30 (LODR)-Cessation -
2026-09-30 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-29 Closure of Trading Window -
2026-09-08 Reg. 34 (1) Annual Report. -
2026-09-05 Record Date For Payment Of Dividend -
2026-09-05 Corporate Action-Board approves Dividend -
2026-09-05 Announcement under Regulation 30 (LODR)-Dividend Updates -
2026-09-05 Notice Of The 28Th Annual General Meeting -
2026-09-05 Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday 05Th September 2026 -
2026-08-27 Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On Saturday 5Th September 2026 -
2026-07-21 Non-Applicability Of Report On Corporate Governance -
2026-07-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-05-30 Board Meeting Outcome for Submission Of Standalone Audited Financial Results For The Year Ended 31 March 2026 -

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 5.53. Market capitalisation stands at ₹46.00 Cr and the dividend yield is 0.04%. The company operates in the Healthcare sector, in the Healthcare Equipment & Supplies industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 21, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.